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a  b  s  t  r  a  c  t
We  report  a case  of a  41-year-old  male  with  end-stage  renal  disease  receiving  chronic  hemodialysis  who
was  referred  to this  hospital  because  of dyspnea.  He had been  on a  regular  dialysis  for 20  years  due  to
chronic  glomerulonephritis.  His  transthoracic  echocardiography  revealed  severe  pulmonary  hyperten-
sion (PH),  and cardiac  catheterization  conﬁrmed  this  diagnosis.  From  clinical  examination  and  review
of  the chest  X-ray  and  computed  tomography  images,  we  thought  PH  was  due  to  multifactorial  mecha-
nisms  typical  of  hemodialysis  patients.  However,  microscopic  examination  of lung  tissue  from  autopsy
specimen  revealed  extensive  calcium  deposits  not  only  in alveolar  septal  wall  but also  in alveolar  capillar-
ies and  small  vessels,  which  had  diffuse  intimal  thickening  causing  the  narrowing  of the  lumens.  Theseemodialysis pathological  ﬁndings  suggest  that  pulmonary  vascular  calciﬁcation  contributed  to  the  PH  in this  patient.
<Learning  objective:  Pulmonary  hypertension  (PH)  is prevalent  and  associated  with  mortality  in  patients
with end-stage  renal  disease  (ESRD).  However,  the  pathogenesis  of  PH  with  ESRD  remains  uncertain.
Here  we  report  a PH  case  receiving  long-term  hemodialysis,  and  whose  pathological  ﬁndings  revealed
extensive  calciﬁcation  in  small  pulmonary  vessels  and  alveolar  capillaries.  This  case  will  provide  evidence
indicating  the causative  role  of  pulmonary  calciﬁcation  for the  development  of  PH in  dialysis  patients.>
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Pulmonary hypertension (PH) is an elevation of pulmonary arte-
ial pressure that can be the result of heart, lung, or systemic
isorders. Regardless of etiology, the morbidity and mortality from
ong-standing PH exceed that expected from the causative condi-
ion [1].
Studies have demonstrated that end-stage renal disease (ESRD)
atients receiving long-term hemodialysis often develop unex-
lained PH, and PH is a strong independent predictor of mortality in
hese patients [2]. The pathogenesis of PH in patients on hemodial-
sis has been known to be multi-factorial and remains to be fully
etermined [3]. Here, we report a male dialysis patient with severe
H whose pathological examination of autopsy lung specimens
howed profound calciﬁcation in small vessels with diffuse inti-
al  thickening as well as scattered calciﬁed deposits surrounding
lveolar capillaries and in alveolar septa. These data suggest the
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causative role of pulmonary vascular calciﬁcation in the develop-
ment of PH in patients with chronic hemodialysis.
Case report
A 41-year-old man  was referred to our hospital for cardiac eval-
uation for dyspnea. At the age of 10 years, he had proteinuria, but he
had refused to receive treatment. At the age of 20, he underwent
thoracoplasty for lung tuberculosis. At the age of 23, he suffered
from dyspnea and edema due to end-stage renal insufﬁciency. Then
he underwent chronic hemodialysis. At that time, his medications
included sevelamer hydrochloride, precipitated calcium carbonate,
allopurinol, and tocopherol nicotinate.
The blood pressure was 108/70 mmHg, and the pulse was  100
beats per minute. He had patent arterio-venous access on left arm,
dilatation of jugular vein, and cardiac assessment revealed a large
heart, and loud pulmonic component of the second heart sound
with holosystolic regurgitant murmur in the tricuspid area. He had
mild hepatomegaly and leg edema.
Laboratory examination revealed low hemoglobin 11.6 g/dl
(normal 13.2–17.3 g/dl), elevated serum creatinine
5.3 mg/dl (normal 0.8–1.2 mg/dl), elevated brain natriuretic
vier Ltd. All rights reserved.
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autopsy.
On microscopical examination of the autopsy specimen of the
lung, there were broad linear calcium deposits in the alveolar septa,
Table 1
Hemodynamic data at cardiac catheterization.
Pulmonary artery pressure (mean) (mmHg) 75/30 (47)
Right ventricular pressure (mmHg) 75/13
Right atrial pressure (mean) (mmHg) 15
F
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eptide 1194.8 pg/ml (normal 0–18.4 pg/dl), serum calcium
.9 mg/dl (normal 8.9–10.5 mg/dl), elevated phosphorus
.8 mg/dl (normal 2.5–4.1 mg/dl), calcium–phosphorus product
7.2 mg2/dl2, and marginally elevated serum parathyroid hormone
70 pg/ml (normal 15–65 pg/ml). There were no abnormal ﬁndings
elated to thrombus and collagen disease.
Arterial blood gas values were normal [arterial oxygen ten-
ion (PaO2) 82 mmHg, arterial carbon dioxide tension (PaCO2)
8 mmHg, and pH 7.44].
Electrocardiogram revealed right-axis deviation and right ven-
ricular hypertrophy.
Chest X-ray showed cardiomegaly (cardiothoracic ratio of 0.70),
ilatation of the pulmonary arteries, lower volume in the right lung
ue to post thoracoplasty, and gland-grass opacity in the bilateral
ower lung (Fig. 1A).
Computed tomography (CT) of the chest showed dilatation of
ulmonary arteries, right heart dilatation, and bilateral ground
lass densities with interlobular thickening, but did not detect
hrombus in pulmonary arteries (Fig. 1B). Complete pulmonary
unction tests revealed mild restrictive abnormality which was  con-
istent with post-thoracoplasty state.
Transthoracic echocardiography showed marked dilatation and
ypertrophy of the right ventricle, which compressed the left ven-
ricle (Fig. 1C and D). Doppler examination measured a tricuspid
egurgitation pressure gradient of 70 mmHg  and a mean pulmonary
rtery pressure (PAP) of 45 mmHg. Left ventricular ejection fraction
as 60% and there was no evidence of left diastolic dysfunction.
hese ﬁndings indicated the presence of severe PH.
ig. 1. (A) Chest X ray showed cardiomegaly, dilatation of the pulmonary arteries, lower v
ilateral lower lung. (B) Chest computed tomography showed bilateral ground glass densit
arasternal long-axis view (C) and parasternal short-axis view (D). There was  massive dillogy Cases 8 (2013) e13–e16
Right heart catheterization revealed elevated PAP, pulmonary
vascular resistance, and right ventricular pressure. It also showed
that cardiac output and pulmonary artery wedge pressure (PAWP)
was normal (Table 1). Left heart catheterization showed signiﬁcant
coronary stenosis in the left anterior descending artery, and normal
left ventricular contraction.
We considered that PH derived from chronic renal failure on
dialysis, because of the absence of thrombosis or embolic episodes,
underlying collagen disease, and normal range of PAWP.
After percutaneous coronary intervention, he started to receive
oral prostacyclin analog and endothelin-1 (ET-1) receptor antago-
nist to reduce PAP. But his symptoms and clinical data relevant to
cardiopulmonary function had gradually deteriorated thereafter.
Two years later, he died from septic shock due to pneumonia
by methicillin-resistant Staphylococcus aureus.  His family agreedPulmonary vascular resistance (dyn s cm−5) 384
Pulmonary artery wedge pressure (mmHg) 13
Cardiac output (L/min) 6.7
Cardiac index (L/min/m2) 3.6
olume in the right lung due to post thoracoplasty, and ground-grass opacity in the
ies with interlobular thickening (arrow). (C and D) Transthoracic echocardiography,
atation and hypertrophy of the right ventricle, which compressed the left ventricle.
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n addition to the scattered ﬁne calcium deposits. Linear calciﬁca-
ion was present in the elastic laminae and medial layers in the
mall vessel walls. These lesions were accompanied by intimal
hickening, which caused luminal narrowing. The alveolar septa
ere diffusely thickened and had abundant collagen ﬁbers in the
nterstitium (Fig. 2). In addition, there were calcium deposits in
ifferent organs including liver, kidney, parathyroid, and arter-
es. Arterial calciﬁcation consisted mainly of medial calciﬁcation.
arathyroid was swollen due to secondary parathyroidism.
These pathological ﬁndings support the hypothesis that the
rogression of PH was attributed to the metastatic pulmonary cal-
iﬁcation in this patient. Imaging of chest radiograph and CT scan
evealing a ground glass opaciﬁcation may  suggest vascular and
nterstitial calciﬁcation rather than pulmonary edema that is com-
only associated with PH in patients with chronic kidney disease.
iscussion
In the present patient, on clinical examination including right
eart catheterization and chest CT, we excluded any apparent
ause of the severe PH. On pathological examination of autopsied
ulmonary specimens, we deemed that pulmonary calciﬁcation
ay  play a major role in PH, because extensive calcium deposits
ere detected in the pulmonary arterial walls and in thickened
nterstitium surrounding capillaries. In addition, there were many
ig. 2. Pathological ﬁndings of the lung autopsy specimen. Fine calciﬁc deposits
long vessel walls (black arrows) and alveolar septa with interstitial ﬁbrosis (white
rrows). Inﬂammatory cells occupy alveolar space [hematoxylin and eosin (H&E),
00×].  Thick circumferential calciﬁc deposits in vessel wall with severely narrowing
f  the lumen due to intimal thickening (H&E, 400×).
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vessels with narrowing of the lumen. These features resemble those
observed in patients with pulmonary arterial hypertension, such
as “plexiform lesion”. Although it is unclear whether this ﬁnding of
intimal thickening is attributed to the reaction derived from pul-
monary calciﬁcation, a previous pathological study showed that
severe cases had linear calciﬁcation of the accompanied by loose
intimal ﬁbrosis with narrowing of the vessel lumens [4]. However,
there have been no reports that related pathological ﬁndings of
the lung with PH in hemodialysis patients. This case supports our
hypothesis that pulmonary calciﬁcation is likely to be important as
one of the multiple etiologies of PH.
PH is relatively common among patients receiving long-term
hemodialysis, and an independent predictor for cardiovascular
mortality [2,4]. The causes of PH in hemodialysis patients are
multifactorial, as described in the Proceedings of the 4th World
Symposium on Pulmonary Hypertension held in 2008 at Dana
Point, California, USA [3]. Those include: (1) the increased pul-
monary circulation due to elevated cardiac output resulting from
the arterio-venous access, concomitant anemia and ﬂuid over-
load; (2) hormonal and metabolic derangement associated with
ESRD which might lead to vasoconstriction of pulmonary vessels
and increased pulmonary vascular resistance; (3) endothelial dys-
function with decreased NO production and accumulation of ET-1
which could reduce the capacity of pulmonary vasoconstriction.
In addition, an increased stiffness of the pulmonary vessels due to
pulmonary vascular calciﬁcation is postulated as a possible mech-
anism of pulmonary hypertension in animal experimental chronic
kidney disease models [5].
What might be the most plausible explanation for extensive
calciﬁcation in this patient? It is becoming clear that vas-
cular calciﬁcation is a highly regulated process involving cell
activity and speciﬁc protein synthesis such as bone formation
[6]. Among many factors contributing to vascular calciﬁcation,
our patient had marked hyperphosphatemia, hypercalcemia, an
elevated calcium-phosphate product, and severe secondary hyper-
parathyroidism, whose intact parathyroid hormone values were
exceeding 600 pg/mL. Thus, we propose that mineral derangement
may  play a predominant role in the development of mineralization
of vascular smooth muscle cells (SMC) and pericytes in alveolar
capillary wall.
Is the vascular calciﬁcation related to intimal thickening in
pulmonary small vessels? Increased attention has focused on the
role of inﬂammation in the development of atherosclerosis and
vascular calciﬁcation [7,8]. Thus, it is possible that both vascu-
lar calciﬁcation and atherosclerosis are inﬂammation-dependent
processes. Although the information on the impact of uremia on
acceleration of intimal thickening in small vessels is limited, contri-
bution of inﬂammation to intimal thickening is likely to be distinct
from that to medial vascular calciﬁcation [9]. Future work will be
obviously necessary to determine the role of hyperphosphatemia
and secondary hyperparathyroidism in vascular SMC  proliferation
in uremic patients.
In conclusion, we report a case of a hemodialysis patient, who
showed severe PH with extensive calciﬁcation in the pulmonary
small vessels and alveolar interstitium surrounding capillaries. We
propose that small pulmonary vessel and capillary wall calciﬁcation
is a possible mechanism of PH in uremic patients with otherwise
unexplained PH.
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